Published in Nature · View the paper (DOI)
Researchers at the Francis Crick Institute found that high doses of sucralose lower activation of T-cells in mice, which could lead to new treatment options for autoimmune diseases. The study suggests that sucralose may be used therapeutically to dampen T-cell responses.
Coverage from 2 institutions